Subscribe
Sign in
Corporate news
PRIME Research
Mar 2
Ibn Sina Pharma [ISPH] – FY2025 Results: Strong Growth in Revenue and Net Profit
Read →
Comments
This site requires JavaScript to run correctly. Please
turn on JavaScript
or unblock scripts
Corporate news
Ibn Sina Pharma [ISPH] – FY2025 Results: Strong Growth in Revenue and Net Profit